News and Trends 6 Jan 2023
C2i Genomics extends AstraZeneca cancer deal
…capabilities and expertise. Transforming cancer detection The industry is continuing to transform the way cancer is detected with the recent developments of cheaper, more cost-effective accessible whole genome sequencing (WGS)…